Multiple sclerosis (MS) is an inflammatory condition of the central nervous system (CNS) that is generally considered an autoimmune condition. White matter tracts are affected, including those of the cerebral hemispheres, infratentorium, and spinal cord. MS lesion may form in the CNS white matter in any location. Continuing lesion formation in MS often leads to physical disability and, sometimes, to cognitive decline.

According to an article on eMedicine.com, gadolinium has been used in studies to monitor the evolution of MS in patients and plan future studies about the disease. Gadolinium is the common name given to a range of compounds of the chemical element gadolinium that are used to enhance magnetic resonance images (MRI). These include gadopentetate dimeglumine, gadoteridol and gadodiamide. In multiple sclerosis, Gadolinium enhancing lesions tend to be associated with an inflammatory response. Inflammatory lesion production is typical of the relapsing-remitting form of the disease and is less often seen in the secondary progressive and the primary progressive form. These finding have allowed medical professionals to predict MS occurrences in patients and plan for proper treatment.

As seen with previous posts about Gadolinium, the potentially debilitating and even fatal medical consequences can occur. If you have been injured as a result of having gadolinium injected into your system, contact the gadolinium lawyers at Williams Kherkher for a free consultation by calling (866) 950-9000.